An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Prif Awdur: | Bristy, Israt Zerin |
---|---|
Awduron Eraill: | Kabir, Md. Tanvir |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
Brac University
2021
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/15619 |
Eitemau Tebyg
-
Molecules associated with the development of lung cancer
gan: Rahman, Adree, et al.
Cyhoeddwyd: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
gan: Shabnam, Musharrat
Cyhoeddwyd: (2018) -
Immunotherapy in the Management of Lung Cancer
gan: Tasnim, Humayra
Cyhoeddwyd: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
gan: Paul, Pulock
Cyhoeddwyd: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
gan: Mim, Shanzida
Cyhoeddwyd: (2023)